PUE-20561-57280
4 vaccinations
2 coded responses
54 check-ins
2 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 454 / OH
- Registered
- 2021-01-12
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Registered dependents
HR9-13599-17208
Child or adolescent in my care · Male · 2021-11-14
48K-28978-33874
Child or adolescent in my care · Male · 2022-06-24
Timeline
-
2021-01-12
Registered in v-safe
-
2021-01-12
Dose 1 — Pfizer-BioNTech
- 2021-01-12
- 2021-01-13
- 2021-01-14
- 2021-01-15
- 2021-01-16
- 2021-01-17
- 2021-01-18
- 2021-01-19
- 2021-01-26
-
2021-02-02
Dose 2 — Pfizer-BioNTech
- 2021-02-02
-
2021-02-03
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Joint pains, Muscle or body achesAdult check-in
- 2021-02-04
- 2021-02-05
- 2021-02-06
- 2021-02-07
- 2021-02-08
- 2021-02-09
- 2021-02-16
- 2021-02-23
- 2021-03-02
- 2021-03-09
- 2021-03-16
- 2021-05-04
- 2021-08-03
-
2021-11-11
Dose 3 — Pfizer-BioNTech
- 2021-11-11
-
2021-11-12
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-11-13
- 2021-11-14
- 2021-11-15
- 2021-11-16
- 2021-11-17
- 2021-11-18
- 2021-11-25
- 2021-12-04
- 2021-12-09
- 2021-12-16
- 2021-12-23
- 2022-02-10
-
2022-05-12
Survey response — 6 months, dose 3MedDRA: COVID-19, Nasopharyngitis, Sinus disorder — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Covid-19, and another cold causing sinus issues.MedDRA releases: 2024-11 · check-in free text available
-
2022-09-16
Dose 4 — ModernaCo-administered: Flu
- 2022-09-16
-
2022-09-17
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Site: Pain · Joint pains, Fatigue or tirednessAdult check-in
- 2022-09-18
- 2022-09-19
- 2022-09-20
- 2022-09-21
- 2022-09-22
- 2022-09-23
- 2022-10-02
- 2022-10-07
- 2022-10-14
- 2022-10-23
- 2022-10-28
-
2022-12-16
Survey response — 3 months, dose 4MedDRA: Influenza — Feeling: Good · Be unable to do your normal daily activitiesFree text: FluMedDRA releases: 2024-11 · check-in free text available
- 2023-03-17
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-12 | Pfizer-BioNTech | |
| 2 | 2021-02-02 | Pfizer-BioNTech | |
| 3 | 2021-11-11 | Pfizer-BioNTech | No |
| 4 | 2022-09-16 | Moderna | Flu |
Free text
Release 11 — 6 months, dose 3
Symptoms: Covid-19, and another cold causing sinus issues.
Release 12 — 3 months, dose 4
Symptoms: Flu
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | COVID-19 | · | · | ✓ |
| SD | Influenza | · | · | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Sinus disorder | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release